%PDF-1.4
%
43 0 obj
<>
endobj
40 0 obj
<>
endobj
93 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-11-29T18:02:03Z
2024-03-28T18:04:40-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T18:04:40-07:00
application/pdf
Heather
201217.oct
uuid:19404203-1dd2-11b2-0a00-f709278d5b00
uuid:19404206-1dd2-11b2-0a00-1e0000000000
endstream
endobj
29 0 obj
<>
endobj
30 0 obj
<>
endobj
44 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
111 0 obj
[115 0 R]
endobj
112 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.005 Tc -0.03239 Tw 9.7 0 0 10 54 713.1616 Tm
(genetically susceptible hosts. In the proposed enthesitis based)Tj
0.0634 Tw 0 -1.2 TD
(model, the additive interactions between biomechanical fac-)Tj
0.1769 Tw T*
(tors and the innate immune response to bacterial products)Tj
0.0715 Tw T*
[(result in disease localization. )17.8 (This model for SpA)-271.6 (may have)]TJ
-0.005 Tc 0.0134 Tw T*
(more general implications for chronic inflammatory disorders.)Tj
/TT1 1 Tf
-0.00011 Tc 0.02499 Tw 3.299 -2.4 Td
(DENNIS McGONAGLE,)Tj
/TT0 1 Tf
0 Tw 5.82 0 0 6 193.4433 641.1616 Tm
(MRCPI,)Tj
0 Tc 0.02499 Tw 7.76 0 0 8 86 631.1616 Tm
[(Lecturer in Rheumatology)64.9 (, MRC Clinical Scientist, )]TJ
-0.00011 Tc 0 -1.25 TD
(University of Leeds, Honorary Consultant, )Tj
T*
(Halifax General Hospital;)Tj
/TT1 1 Tf
9.7 0 0 10 86 599.1616 Tm
[(LUKE ST)17.7 (OCKWIN,)]TJ
/TT0 1 Tf
0 Tw 5.82 0 0 6 175.5044 599.1616 Tm
(BSc,)Tj
0 Tc 0.0249 Tw 7.76 0 0 8 86 589.1616 Tm
[(Research Fellow)64.9 (, School of Biochemistry and Molecular Biology)64.9 (,)]TJ
-0.00011 Tc T*
(University of Leeds;)Tj
/TT1 1 Tf
-0.0002 Tc 9.7 0 0 10 86 567.1616 Tm
(JOHN ISAACS,)Tj
/TT0 1 Tf
-0.01241 Tc 5.82 0 0 6 156.2678 567.1616 Tm
(PhD, FRCP,)Tj
0 Tc 7.76 0 0 8 86 557.1616 Tm
(Senior Lecturer in Rheumatology;)Tj
/TT1 1 Tf
-0.00011 Tc 0 Tw 9.7 0 0 10 86 545.1616 Tm
[(P)73.9 (AUL)-220.2 (EMER)34.8 (Y)91.9 (,)]TJ
/TT0 1 Tf
-0.01401 Tc 0.02499 Tw 5.82 0 0 6 153.7812 545.1616 Tm
(MD, FRCP,)Tj
0 Tc 7.76 0 0 8 86 535.1616 Tm
[(ARC Professor in Rheumatology)64.9 (, Department of Rheumatology)64.9 (, )]TJ
-0.00011 Tc T*
(University of Leeds.)Tj
/TT2 1 Tf
-0.0041 Tw -4.1237 -2.75 Td
[(Addr)36.8 (ess r)36.8 (eprint r)36.8 (equests to Dr)110.7 (. D. McGonagle, Department of Rheumatology)54.8 (,)]TJ
0.2747 Tw T*
[(36 Clar)36.8 (endon Road, University of Leeds, Leeds LS2 9NZ, UK. E-mail:)]TJ
0 Tc 0 Tw T*
(d.g.mcgonagle@leeds.ac.uk)Tj
/TT1 1 Tf
-0.00011 Tc 9.7 0 0 10 54 459.1616 Tm
(REFERENCES)Tj
/TT0 1 Tf
0.02499 Tw 8 0 0 8 61 449.1616 Tm
[(1.)-875.1 (Calin )54.8 (A, )17.7 (T)69.7 (aurog JD. )17.7 (The spondylarthritides. 2nd ed. Oxford: Oxford)]TJ
1.675 -1.25 Td
(University Press; 1998.)Tj
-1.675 -1.25 Td
[(2.)-875.1 (Molber)17.7 (g O, McAdam SN, Korner R, et al. )17.7 (T)34.8 (issue transglutaminase)]TJ
0 Tc 1.675 -1.25 Td
(selectively modifies gliadin peptides that are recognized by gut-)Tj
T*
[(derived )17.8 (T)-257.2 (cells in celiac disease. Nature Med 1998;4:713-7.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (McGonagle D, Gibbon )17.7 (W)91.7 (, O\222Connor P)110.7 (, Green M, Pease C, Emery)]TJ
0 Tc 1.675 -1.25 Td
[(P)111.1 (. Characteristic MRI entheseal changes of knee synovitis in)]TJ
T*
[(spondyloarthropathy)65 (. )54.9 (Arthritis Rheum 1998;41:694-700.)]TJ
-1.675 -1.25 Td
[(4.)-875 (McGonagle D, Gibbon )17.7 (W)91.8 (,)0.1 ( Emery P)110.8 (. Classification of inflammatory)]TJ
1.675 -1.25 Td
[(arthritis by enthesitis. Lancet 1998:353:1)36.9 (137-40.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(5.)-875.1 (McGonagle D, Khan MA, Marzo-Ortega H, O\222Connor P)110.7 (,)-0.1 ( Gibbon)]TJ
0 Tc 1.675 -1.25 Td
[(W)91.8 (,)0.1 ( Emery P)110.8 (. Enthesitis in spondyloarthropathy)64.9 (. Curr Opin)]TJ
T*
[(Rheumatol 1999;1)36.9 (1:244-50.)]TJ
-1.675 -1.25 Td
[(6.)-875 (Benjamin M, Ralphs JR. Fibrocartilage in tendons and ligaments \227)]TJ
1.675 -1.25 Td
[(an adaptation to compressive loads. J )54.9 (Anat 1998;193:481-94.)]TJ
-1.675 -1.25 Td
[(7.)-875 (Benjamin M, Ralphs JR. )17.8 (T)69.8 (endons and ligaments \227 an overview)64.9 (.)]TJ
1.675 -1.25 Td
[(Histol Histopathol 1997;12:1)36.9 (135-44.)]TJ
-1.675 -1.25 Td
[(8.)-875 (Rufai )54.9 (A, Ralphs JR, Benjamin M. Structure and histopathology of)]TJ
1.675 -1.25 Td
[(the insertional region of the human )54.8 (Achilles tendon. J Orthop Res)]TJ
0 Tw T*
(1995;13:585-93.)Tj
0.0249 Tw -1.675 -1.25 Td
[(9.)-875 (Canoso JJ. )17.7 (The premiere enthesis. J Rheumatol 1998;25:1254-6.)]TJ
-0.5 -1.25 Td
[(10.)-875 (Poole )54.9 (AR. )17.8 (The histopathology of ankylosing spondylitis: are there)]TJ
2.175 -1.25 Td
[(unifying hypotheses? )54.9 (Am J Med Sci 1998;316:228-33.)]TJ
-2.1381 -1.25 Td
[(1)36.9 (1.)-875 (Leroux JY)128.9 (, Guerassimov )54.8 (A, Cartman )54.8 (A, et al. Immunity to the G1)]TJ
2.1381 -1.25 Td
(globular domain of cartilage proteoglycan aggrecan can induce)Tj
T*
(inflammatory erosive polyarthritis and spondylitis in BALB/c mice)Tj
T*
(but immunity to G1 is inhibited by covalently bound keratin)Tj
T*
(sulphate. J Clin Invest 1996;97:621-32.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(12.)-875.1 (McGonagle D, Conaghan P)110.7 (, Emery P)110.7 (. Psoriatic arthritis \227 a unified)]TJ
0 Tc 2.175 -1.25 Td
[(concept twenty years on. )54.9 (Arthritis Rheum 1999;42:1080-6.)]TJ
-2.175 -1.25 Td
[(13.)-875 (Casserly IP)110.8 (, Fenlon HM, Breatnach E, Sant SM. Lung findings on)]TJ
2.175 -1.25 Td
(high-resolution computed tomography in idiopathic ankylosing)Tj
T*
(spondylitis \227 correlation with clinical findings, pulmonary)Tj
T*
[(function testing and plain radiography)64.9 (. Br J Rheumatol)]TJ
0 Tw T*
(1997;36:677-82.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(14.)-875.1 (Francke U, Furthmayr H. Marfan\222)54.8 (s syndrome and other disorders of)]TJ
0 Tc 2.175 -1.25 Td
(fibrillin. N Engl J Med 1994;330:1384-5.)Tj
30.825 78.171 Td
[(15.)-875 (Arayssi )17.7 (T)74 (,)0.1 ( Duray P)110.8 (, Crane M, Lee J, Klippel J, Schumacher HR.)]TJ
2.175 -1.25 Td
[(The spectrum of normal synovial histology [abstract]. )54.9 (Arthritis)]TJ
T*
(Rheum 1997;40 Suppl:S251.)Tj
-0.0224 Tw -2.175 -1.25 Td
[(16.)-875 (Ando J, )17.8 (T)69.8 (suboi H, Korenaga R, et al. Dif)17.8 (ferential display and cloning)]TJ
-0.00011 Tc 0.1808 Tw 2.175 -1.25 Td
(of shear stress-responsive messenger RNAs in human endothelial)Tj
0 Tc 0.02499 Tw T*
(cells. Biochem Biophys Res Commun 1996;225:2158347-51.)Tj
-2.175 -1.25 Td
[(17.)-875 (Resnick N, Collins )17.7 (T)74 (, )54.8 (Atkinson )17.7 (W)91.8 (, Bonthron DT)74 (, Dewey CF Jr)39.8 (,)]TJ
2.175 -1.25 Td
[(Gimbrone MA)-220.1 (Jr)54.9 (. Platelet-derived growth factor B chain promoter)]TJ
T*
[(contains a cis-acting fluid shear)19.8 (-stress-responsive element. Proc)]TJ
-0.00011 Tc T*
[(Natl )54.8 (Acad Sci USA)-220.2 (1993;90:4591-5.)]TJ
0 Tc -2.175 -1.25 Td
[(18.)-875 (Lan Q, Mercurius KO, Davies PF)79.8 (. Stimulation of transcription)]TJ
2.175 -1.25 Td
[(factors NF kappa B and )54.8 (AP1 in endothelial cells subjected to shear)]TJ
T*
(stress. Biochem Biophys Res Comm 1994;201:950-6.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(19.)-875.1 (Liang F)79.7 (, Gardner DG. Mechanical strain activates BNP)-238.3 (gene)]TJ
0 Tc 2.175 -1.25 Td
(transcription through a p38/NF-kB-dependent mechanism. J Clin)Tj
T*
(Invest 1999;104:1603-12.)Tj
-2.175 -1.25 Td
[(20.)-875 (Singer )54.9 (AJ, Clark RA. Cutaneous wound healing. N Engl J Med)]TJ
0 Tw 2.175 -1.25 Td
(1999;341:738-46.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(21.)-875.1 (Schulz LC, Schaening U, Pena M, Hermanns M. Borderline tissues)]TJ
0 Tc 2.175 -1.25 Td
(as sites of antigen deposition and persistence \227 a unifying concept)Tj
T*
(for rheumatoid inflammation? Rheumatol Int 1985;5:21-7.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(22.)-875.1 (Sieper J, Kingsley GH, Braun J. Report on the Fourth International)]TJ
0 Tc 2.175 -1.25 Td
[(W)79.8 (orkshop on Reactive )54.9 (Arthritis. )54.9 (Arthritis Rheum 2000;43:720-34.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(23.)-875.1 (Gerard HC, Branigan PJ, Schumacher HR Jr)39.7 (, Hudson )54.8 (AP)110.7 (. Synovial)]TJ
0 Tc 2.175 -1.25 Td
[(Chlamydia trachomatis in patients with reactive arthritis/Reiter)-36.9 (\222)55.2 (s)]TJ
T*
(syndrome are viable but show aberrant gene expression. )Tj
T*
(J Rheumatol 1998;25:734-42.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(24.)-875.1 (Deng GM, Nilsson IM, )17.7 (V)111 (erdrengh M, Collins L)91.7 (V)129.1 (, )17.7 (T)69.7 (arkowski )54.8 (A.)]TJ
2.175 -1.25 Td
[(Intra-articularly localized bacterial DNA)-220.2 (containing CpG motifs)]TJ
0 Tc T*
(induces arthritis. Nature Med 1998;5:702-5.)Tj
-2.175 -1.25 Td
[(25.)-875 (L)54.9 (ydyard PM, van Eden )17.8 (W)91.8 (. Heat shock proteins: immunity and)]TJ
2.175 -1.25 Td
[(immunopathology)64.9 (. Immunol )17.8 (T)69.8 (oday 1990;1)36.9 (1:228-9.)]TJ
-2.175 -1.25 Td
[(26.)-875 (Audibert FM, Lise LD. )54.8 (Adjuvants: current status, clinical)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(perspectives and future prospects. Immunol )17.7 (T)69.7 (oday 1993;14:281-4.)]TJ
-2.175 -1.25 Td
[(27.)-875.1 (McGonagle D, Marzo-Ortega H, Pease C, Gibbon )17.7 (W)91.7 (, O\222Connor P)110.7 (,)]TJ
0 Tc 2.175 -1.25 Td
[(Emery P)110.8 (. )17.7 (The MRI, microbiological and histological assessment of)]TJ
T*
[(the acute enthesitis lesion [abstract]. )54.9 (Arthritis Rheum 1999;42)]TJ
0 Tw T*
(Suppl:S1853.)Tj
0.0249 Tw -2.175 -1.25 Td
[(28.)-875 (Y)100.1 (ang RB, Mark MR, Gray )54.8 (A, et al. )17.7 (T)69.8 (oll-like receptor)19.8 (-2 mediates)]TJ
2.175 -1.25 Td
(lipopolysaccharide-induced cellular signalling. Nature)Tj
0 Tw T*
(1998;395:284-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(29.)-875.1 (Y)55.1 (i)-0.1 ( )54.8 (AK, )17.7 (T)34.8 (uetken R, Redford )17.7 (T)73.9 (,)-0.1 ( )17.7 (W)79.7 (aldschmidt M, Kirsch J, Krieg)]TJ
2.175 -1.25 Td
[(AM. CpG motifs in bacterial DNA)-220.2 (activate leukocytes through the)]TJ
0 Tc T*
(pH-dependent generation of reactive oxygen species. J Immunol)Tj
0 Tw T*
(1998;160:4755-61.)Tj
0.0249 Tw -2.175 -1.25 Td
[(30.)-875 (Kol )54.8 (A, Bourcier )17.7 (T)74 (, Lichtman )54.8 (AH, Libby P)110.8 (. Chlamydial and human)]TJ
2.175 -1.25 Td
(heat shock protein 60s activate human vascular endothelium,)Tj
T*
(smooth muscle cells, and macrophages. J Clin Invest)Tj
0 Tw T*
(1999;103:571-7.)Tj
0.02499 Tw -2.175 -1.25 Td
[(31.)-875 (Lorentzen JC. Identification of arthritogenic adjuvants of self and)]TJ
2.175 -1.25 Td
(foreign origin. Scand J Immunol 1999;49:45-50.)Tj
-2.175 -1.25 Td
[(32.)-875 (Matzinger P)110.8 (. )17.7 (T)69.8 (olerance, danger and the extended family)64.9 (. )54.8 (Ann Rev)]TJ
2.175 -1.25 Td
(Immunol 1994;12:991-1045.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(33.)-875.1 (W)39.7 (ilkinson NZ, Kingsley GH, Jones HW)91.7 (, Sieper J, Braun J, )17.7 (W)79.7 (ard)]TJ
0 Tc 2.175 -1.25 Td
[(ME. )17.7 (The detection of DNA)-220.1 (from a range of bacterial species in the)]TJ
T*
(joints of patients with a variety of arthritides using a nested, broad-)Tj
T*
(range polymerase chain reaction. Rheumatology 1999;38:260-6.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(34.)-875.1 (Ross R. )54.8 (Atherosclerosis an inflammatory disease. N Engl J Med)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
[(1999;340:1)36.9 (15-26.)]TJ
0.0249 Tw -2.175 -1.25 Td
[(35.)-875 (Hu H, Pierce GN, Zhong G. )17.7 (The atherogenic ef)17.8 (fects of chlamydia)]TJ
2.175 -1.25 Td
(are dependent on serum cholesterol and specific to Chlamydia)Tj
T*
(pneumoniae. J Clin Invest 1999;103:747-53.)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT2 1 Tf
8 0 0 8 54.5 35.9844 Tm
(McGonagle, et al: Editorial)Tj
0 Tw 60.9375 -0.0313 Td
(2159)Tj
ET
0 0 0 0 scn
/GS0 gs
103.18 58.75 407.5 -10.83 re
f*
0.5 w
103.18 58.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
82 0 obj
<>
endobj
98 0 obj
<>
endobj
50 0 obj
<>
endobj
57 0 obj
<>
endobj
47 0 obj
<>
endobj
46 0 obj
<>
endobj
74 0 obj
<>stream
HVpMg}9ބ(yȃsHInG/]P!^yHi*RdhWյvlRm2YE]cL=ZڙΞ@TCAzM:LR:"PuzL bUq|} h*gTL bxia٭\`ȿK%.761Z. ꐖD~JKy:z&P#^]@ݿ&e,7߅ˁPD{ѧrMjP[Z8Bm>QEJ
F
ipjdzj ~
tch$6b9n#1K\PKGy 蟆X8SYg@wc#U0ҳ
k;H0< S8*
_X'rw)"E'@4brDzr5^
`{Va1UW,ӈ~a=>D2bmַА;3Pø4p\e%!"W,o)neK:[wO;ʽrkNM;D%b8bE2Gpj\1NT%Z,b->Y2_N
<.O/y]D*)5>WZ6M[Uk; M
M
U-m[UbkUϮ~d";\)ba{\zndc;afw]?:wyN=pf4A|Q$iL9U9o0b)⦸j2Jdg<